HUBUNGAN ANTARA DERAJAT KOMORBID HIPERTENSI DENGAN TINGKAT KEPARAHAN COVID-19 DI RS SITI KHADIJAH SEPANJANG PEDIODE 2021
DOI:
https://doi.org/10.30651/jmu.v1i01.21513Kata Kunci:
COVID-19, komorbid hipertensi, tingkat keparahan COVID-19Abstrak
Latar
belakang : disease-19 (COVID-19) telah ditetapkan oleh WHO sebagai pandemi dunia dikarenakan penyebaran infeksi yang menyebar dengan cepat di berbagai belahan dunia. Virus ini menyebabkan berbagai infkesi saluran pernapasan pada manusia yang bervariasi mulai dari flu ringan hingga sindrom gangguang pernapasan berat. Banyak penelitian menyebutkan bahwa hipertensi merupakan
komorbid umum pada pasien positif COVID-19. Hipertensi pada pasien COVID-19 diyakini dapat memperparah keadaan pasien dikarenakan terapi pasien positif COVID-19 dengan hipertensi lebih sulit dibanding pasien positif COVID-19 tanpa hipertensi. Tujuan : mengetahui hubungan antara derajat hipertensi dengan tingkat keparahan COVID-19 di Rumah Sakit Siti Khodijah Muhammadiyah Cabang Sepanjang. Metode : Penelitian ini menggunakan jenis penelitian analitik observasional dengan pendekatan cross sectional. Sampel dipilih dengan Teknik total sampling. Sampel yang digunakan dalam penelitian ini berjumlah 86 orang dan sampel merupakan pasien terkonfirmasi COVID-19 di Rumah Sakit Siti Khodijah Muhammadiyah Cabang Sepanjang yang masuk dalam kriteria inklusi. Data dianaliis menggunakan uji rank spearman. Hasil : Berdasarkan hasil uji rank spearman hubungan derajat komorbid hipertensi dengan tingkat keparahan pasien COVID-19 didapatkan p=0,268 (p>0,05) dan koefisien korelasi rank spearman= 0.121. Kesimpulan : Tidak terdapat hubungann antara komorbid hipertensi dengan tingkat keparahan COVID-19.
Kata kunci: COVID-19, komorbid hipertensi, tingkat keparahan COVID-19
Referensi
Aditia, A. (2021) ‘COVID-19 : EPIDEMIOLOGI, VIROLOGI, PENULARAN, GEJALA KLINIS, DIAGNOSA, TATALAKSANA, FAKTOR RISIKO DAN PENCEGAHAN’, Jurnal Penelitian Perawat Profesional, 3(November), pp. 653–660. Available at: http://jurnal.globalhealthsciencegroup. com/index.php/JPPP%0ACOVID-19.
Alkautsar, A. (2021) ‘Hubungan Penyakit Komorbid Dengan Tingkat Keparahan Pasien Covid-19’, Jurnal Medika Hutama, 03(01), pp. 402–406.
Arif Gunawan, Kartika Prahasanti, Muhamad Reza Utama, M. P. A. (2020)
‘PENGARUH KOMORBID
HIPERTENSI TERHADAPSEVERITAS PASIEN CORONAVIRUS DISEASE 2019’, Universitas Muhammadiyah Surabaya, 1(2), pp. 136–151.
Beevers, G., Lip, G. Y. and O’Brien, E. (2001) ‘ABC of hypertension: The pathophysiology of hypertension.’, BMJ (Clinical research ed.), 322(7291), pp. 912–6. doi: 10.1136/bmj.322.7291.912.
Burhan, E. (2020) Tatalaksana Klinis COVID- 19, Kemenkes Ri.
Chen, Y. et al. (2021) ‘Aging in COVID-19: Vulnerability, immunity and
intervention’, Ageing Research Reviews, 65(August 2020), p. 101205. doi: 10.1016/j.arr.2020.101205.
Cheng, W. L. (2019) Interpretation of the 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension, Chinese General Practice. doi: 10.12114/j.issn.1007- 9572.2019.00.224.
D’Elia, L. et al. (2022) ‘Hypertension and mortality in SARS-COV-2 infection: A meta-analysis of observational studies after 2 years of pandemic’, European Journal of Internal Medicine, 108(July 2022), pp. 28–36. doi: 10.1016/j.ejim.2022.11.018.
Fang, L., Karakiulakis, G. and Roth, M. (2020) ‘Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?’, The Lancet Respiratory Medicine, 8(4), p. e21. doi: 10.1016/S2213-2600(20)30116-8.
Fuchs, F. D. and Whelton, P. K. (2020) ‘High Blood Pressure and Cardiovascular Disease’, Hypertension, (Cvd), pp. 285–292. doi: 10.1161/HYPERTENSIONAHA.119. 14240.
Gao, Y. dong et al. (2021) ‘Risk factors for severe and critically ill COVID-19
Medical and Health Science Journal, Vol.., No.,
patients: A review’, Allergy: European Journal of Allergy and Clinical Immunology. Blackwell Publishing Ltd, pp. 428–455. doi: 10.1111/all.14657.
Green, L. (2003) JNC 7 Express: The Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. U.S. Department of Health and Human Services.
Harapan, H. et al. (2020) ‘Coronavirus disease 2019 (COVID-19): A literature review’, Journal of Infection and Public Health, 13(5), pp. 667–673. doi: 10.1016/j.jiph.2020.03.019.
Huang, C. et al. (2020) ‘Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China’, The Lancet, 395(10223), pp. 497–506. doi: 10.1016/S0140-6736(20)30183-5.
Iaccarino, G. et al. (2020) ‘Age and multimorbidity predict death among COVID-19 Patients: Results of the SARS-RAS study of the Italian society of hypertension’, Hypertension, 76(2), pp. 366–372. doi: 10.1161/HYPERTENSIONAHA.120.1 5324.
Judd, E. and Calhoun, D. A. (2014) ‘Apparent and true resistant hypertension: Definition, prevalence and outcomes’, Journal of Human Hypertension, 28(8), pp. 463–468. doi: 10.1038/jhh.2013.140.
Kadir, A. (2018) ‘Hubungan Patofisiologi Hipertensi dan Hipertensi Renal’, Jurnal Ilmiah Kedokteran Wijaya Kusuma, 5(1), p. 15. doi: 10.30742/jikw.v5i1.2.
Kemenkes RI (2013) ‘Pedoman Teknis Penemuan dan Tatalaksana
Hipertensi’.
Kemenkes RI (2020) 13,2 PERSEN PASIEN COVID-19 YANG MENINGGAL MEMILIKI PENYAKIT HIPERTENSI, KEMENTERIAN KESEHATAN REPUBLIK INDONESIA. Available at: https://www.kemkes.go.id/article/print /20101400002/13-2-persen-pasien- covid-19-yang-meninggal-memiliki- penyakit-hipertensi.html (Accessed: 13 January 2022).
Kemenkes RI (2022) Peta Sebaran COVID- 19. Available at:
https://covid19.go.id/peta-sebaran (Accessed: 13 January 2022).
Kuba, K. et al. (2005) ‘A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury’, Nature Medicine, 11(8), pp. 875–879. doi: 10.1038/nm1267.
Levani, Y., Prastya, aldo dwi and Mawaddatunnadila, S. (2021) ‘Coronavirus Disease 2019 (COVID- 19): Patogenesis, Manifestasi Klinis dan Pilihan Terapi’, Jurnal Kedokteran dan Kesehatan, 17(1), pp. 44–57. Available at: https://jurnal.umj.ac.id/index.php/JKK/ article/view/6340.
Manolis, A. S. et al. (2020) ‘Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information ’, (January).
Nuzzo, J. et al. (2022) Coronavirus COVID- 19 global cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU), JOHNS HOPKINS UNIVESITY OF MEDICINE. Available at: https://coronavirus.jhu.edu/map.html (Accessed: 13 January 2022).
Medical and Health Science Journal, Vol.., No.,
PDPI et al. (2020) Pedoman tatalaksana COVID-19 Edisi 3 Desember 2020, Pedoman Tatalaksana COVID-19. Available at: https://www.papdi.or.id/download/983 -pedoman-tatalaksana-covid-19-edisi- 3-desember-2020.
Pezel, T. et al. (2021) ‘Prognostic value of pre-hospitalization stress perfusion cardiovascular magnetic resonance to predict death in patients hospitalized for COVID-19’, Archives of Cardiovascular Diseases, 114(12), pp. 781–792. doi: 10.1016/j.acvd.2021.10.004.
Ramasamy, S. and Subbian, S. (2021) ‘Critical determinants of cytokine storm and type i interferon response in COVID-19 pathogenesis’, Clinical Microbiology Reviews, 34(3). doi: 10.1128/CMR.00299-20.
Richardson, S. et al. (2020) ‘Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area’, JAMA - Journal of the American Medical Association, 323(20), pp. 2052–2059. doi: 10.1001/jama.2020.6775.
Te Riet, L. et al. (2015) ‘Hypertension: Renin-Angiotensin-Aldosterone System Alterations’, Circulation Research, 116(6), pp. 960–975. doi: 10.1161/CIRCRESAHA.116.303587.
Sahu, P. (2020) ‘Closure of Universities Due to Coronavirus Disease 2019 (COVID- 19): Impact on Education and Mental Health of Students and Academic Staff’, Cureus, 2019(4), pp. 4–9. doi: 10.7759/cureus.7541.
Satuan Gugus Tugas COVID-19 (2021) ‘Tren COVID-19 Jawa Timur di Masa PPKM’.
Schiffrin, E. L. et al. (2020) ‘Hypertension and COVID-19’, American Journal of Hypertension. Oxford University
Press, pp. 373–374. doi: 10.1093/ajh/hpaa057.
Shahbaz, S. et al. (2021) ‘Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS- CoV-2’, Stem Cell Reports, 16(5), pp. 1165–1181. doi: 10.1016/j.stemcr.2021.04.001.
Shibata, S. et al. (2022) ‘COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID- 19’, Hypertension Research, pp. 589– 600. doi: 10.1038/s41440-022-01134- 5.
Sugihantono, A. et al. (2020) Pedoman Pencegahan dan Pengendalian Coronavirus Disease 2019 (COVID- 19). 5th edn, Kementrian Kesehatan Republik Indonesia. 5th edn. Jakarta: Kementrian Kesehatan Republik Indonesia. doi: 10.33654/math.v4i0.299.
Suni, N. S. P. (2021) ‘Tingginya Kasus Aktif dan Angka Kematian Akibat Covid-19 di Indonesia’, Jurnal Pusat Penelitian Badan Keahlian DPR RI, 13(3), pp. 13–18. Available at: https://berkas.dpr.go.id/puslit/files/info _singkat/Info Singkat-XIII-3-I-P3DI- Februari-2021-1957.pdf.
Susilo, A. et al. (2020) ‘Coronavirus Disease 2019: Tinjauan Literatur Terkini’, Jurnal Penyakit Dalam Indonesia, 7(1), p. 45. doi: 10.7454/jpdi.v7i1.415.
Tirtasari, S. and Kodim, N. (2019) ‘Prevalensi dan Karakteristik Hipertensi Pada Usia Dewasa Muda di Indonesia’, Tarumanagara Medical Journal, 1(2), pp. 395–402.
Tsani, I. (2021) ‘Imtiyaz Tsany’, pp. 1–66.
Umakanthan, S. et al. (2020) ‘Origin, transmission, diagnosis and
management of coronavirus disease 2019 (COVID-19)’, Postgraduate
Medical and Health Science Journal, Vol.., No.,
Medical Journal. BMJ Publishing Group, pp. 753–758. doi: 10.1136/postgradmedj-2020-138234.
Wu, C. et al. (2020) ‘Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China’, JAMA Internal Medicine, 180(7), pp. 934–943. doi: 10.1001/jamainternmed.2020.0994.
Wu, F. et al. (2020) ‘A new coronavirus associated with human respiratory disease in China’, Nature, 579(7798), pp. 265–269. doi: 10.1038/s41586- 020-2008-3.
Zaki, N., Alashwal, H. and Ibrahim, S. (2020) ‘Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review’, Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(5), pp. 1133–1142. doi: 10.1016/j.dsx.2020.07.005.
Zhang, J. jin et al. (2023) ‘Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality’, Clinical Reviews in Allergy and Immunology, 64(1), pp. 90–107. doi: 10.1007/s12016-022-08921-5.
El Zowalaty, M. E. and Järhult, J. D. (2020) ‘From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans – Call for a One Health approach’, One Health, 9(February), p. 100124. doi: 10.1016/j.onehlt.2020.100124.
